About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Orofacial Manifestations of Sturge-Weber Syndrome
Ramneek Bansal1, Divye Malhotra1, Amit Goel2, Shubh Karmanjit Singh Bawa2, Parul Sharma2, Steffy Bansal3
Departments of 1Oral Surgery and 2Oral Periodontics, Himachal Dental College, Sundernagar, Mandi, Himachal Pradesh; 3Private Practice, Himachal Pradesh, India.
Corresponding Author:
Dr. Ramneek Bansal
Email: ramneekkumar70@yahoo.co.in
Received: 29-MAY-2020 Accepted: 30-AUG-2020 Published Online: 30-OCT-2020
DOI: http://dx.doi.org/10.17659/01.2020.0059
Abstract
Background: Sturge-Weber syndrome is a rare neurocutaneous condition, also known as angiomatosis of the encephalotrigeminals. It has varied systemic and oral manifestations, and the challenge for a dental practitioner is to manage oral condition in such a case. Case Report: We hereby report Sturger-Weber syndrome with dermatological and intraoral manifestations. The lesion had an uneventful healing following gingivectomy and flap surgery. Conclusion: Gingivectomy and flap surgery is an option to manage gingival overgrowth.
Keywords : Angiomatosis, Dentists, Gingival Overgrowth, Gingivectomy, Sturge-Weber Syndrome.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025